Valink Therapeutics

Winter 2021Active

Discovering bispecific antibody drug-conjugates (BsADC) against cancer

Save

Valink Therapeutics

Winter 2021Active

Discovering bispecific antibody drug-conjugates (BsADC) against cancer

Save

Company details

Valink Therapeutics develops next generation antibody-based therapeutics. We identify novel mechanism of action from known targets by incorporating multiple antibody modifications at once, rapidly and scalable generating complex drug candidates (bi-/multispecificity, multivalency and drug-conjugation in a single discovery process). Our research focus is on solid tumours poorly addressed by immunotherapy.

Location

Boston, MA, USA

Founded

Unknown

Request the Valink Therapeutics report.

Valink Therapeutics has no report yet. Sign in with your email to request one.